ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
256.96
+1.08 (0.42%)
Jul 3, 2025, 1:00 PM - Market closed
ResMed Employees
ResMed had 9,980 employees as of June 30, 2024. The number of employees decreased by 160 or -1.58% compared to the previous year.
Employees
9,980
Change (1Y)
-160
Growth (1Y)
-1.58%
Revenue / Employee
$503,159
Profits / Employee
$131,589
Market Cap
37.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9,980 | -160 | -1.58% |
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | 7,770 | 530 | 7.32% |
Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
Jun 30, 2018 | 5,940 | -140 | -2.30% |
Jun 30, 2017 | 6,080 | 830 | 15.81% |
Jun 30, 2016 | 5,250 | 910 | 20.97% |
Jun 30, 2015 | 4,340 | 240 | 5.85% |
Jun 30, 2014 | 4,100 | 200 | 5.13% |
Jun 30, 2013 | 3,900 | 200 | 5.41% |
Jun 30, 2012 | 3,700 | 250 | 7.25% |
Jun 30, 2011 | 3,450 | 250 | 7.81% |
Jun 30, 2010 | 3,200 | 300 | 10.34% |
Jun 30, 2009 | 2,900 | 200 | 7.41% |
Jun 30, 2008 | 2,700 | 0 | - |
Jun 30, 2007 | 2,700 | 200 | 8.00% |
Jun 30, 2006 | 2,500 | 573 | 29.74% |
Jun 30, 2005 | 1,927 | 407 | 26.78% |
Jun 30, 2004 | 1,520 | 56 | 3.83% |
Jun 30, 2003 | 1,464 | 214 | 17.12% |
Jun 30, 2002 | 1,250 | 297 | 31.16% |
Jun 30, 2001 | 953 | 348 | 57.52% |
Jun 30, 2000 | 605 | 104 | 20.76% |
Jun 30, 1999 | 501 | 111 | 28.46% |
Jun 30, 1998 | 390 | 106 | 37.32% |
Jun 30, 1997 | 284 | 55 | 24.02% |
Jun 30, 1996 | 229 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
RMD News
- 3 days ago - Top 15 High-Growth Dividend Stocks For July 2025 - Seeking Alpha
- 3 days ago - Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 - GlobeNewsWire
- 25 days ago - ResMed: A Sleeping Giant Hiding In Plain Sight - Seeking Alpha
- 4 weeks ago - Top 15 High-Growth Dividend Stocks For June 2025 - Seeking Alpha
- 7 weeks ago - Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 - GlobeNewsWire
- 2 months ago - Top 15 High-Growth Dividend Stocks To Consider For May 2025 - Seeking Alpha
- 2 months ago - Resmed Acquires VirtuOx - GlobeNewsWire
- 2 months ago - ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast - Benzinga